PhaseV Launches AI-Powered Enrollment Lab: Eliminating Guesswork and Grounding Study Design in Clinical Reality

PhaseV Launches AI-Powered Enrollment Lab: Eliminating Guesswork and Grounding Study Design in Clinical Reality News provided by PhaseV Feb 02, 2026, 08:30 ET Share this article Share to X Share this article Share to X Unveiled at SCOPE Summit, The Virtual Solution Leverages Real-World EHR Data to Quantify Patient-Level Competition and Eligibility Before Protocol Lock BOSTON , Feb. 2, 2026 /PRNewswire/ -- PhaseV, a leader in AI/ML for clinical development, today announced the launch of its new Enrollment Lab solution at the 17th Annual SCOPE Summit . A high-impact addition to the PhaseV ClinOps platform , this AI-powered solution enables sponsors to quantify a study's true enrollment potential and model the impact of protocol trade-offs prior to protocol lock. The Enrollment Lab: Impact of eligibility criteria adjustments on the eligible patient population and competitive landscape.